SPRC (SciSparc) Aset Bersih Perusahaan

SciSparc Ltd (SPRC) develops cannabinoid-based medications to combat Alzheimer's disease and Tourette syndrome, protecting high margins with a strong patent portfolio. This price action for the securities on GURU.Markets captured the 0.00 metric. The business leverages the expanding neurology market while implementing "green chemistry" methods to reduce production toxicity and wastewater treatment as part of its ESG strategy.

SPRC Kapitalisasi Buku SciSparc Corp (21.02.2024 - 28.10.2026)

SciSparc Ltd. maintains stability through robust diversification of its logistics hubs, ensuring uninterrupted drug distribution and high margins. By analyzing total equity through the current state of balance sheet capitalization, investors assess the business's ability to accumulate resources and withstand market shocks, utilizing the dynamics of this metric to identify asset overvaluation and protect portfolios from sector crises.